These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2665219)

  • 1. Evidence that matching for HLA antigens significantly increases transplant survival in 1001 renal transplants performed in the northwest region of England.
    Dyer PA; Johnson RW; Martin S; Bakran A; Gokal R; Harris R; Mallick NP; Manos J; Orr WM; Pearson RC
    Transplantation; 1989 Jul; 48(1):131-5. PubMed ID: 2665219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mismatching for HLA-DR in recipients of renal allografts sharing one HLA-ABC haplotype with related donors.
    Sutherland DE; Morrow CE; Kaufman D; Fryd DS; Najarian JS; Burke M; Noreen H; Segall M; Bach FH
    Transplantation; 1983 Dec; 36(6):643-7. PubMed ID: 6362140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year results of renal transplantation in highly sensitized recipients. Collaborative Transplant Study.
    Opelz G
    Transpl Int; 1996; 9 Suppl 1():S16-9. PubMed ID: 8959781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients.
    Cicciarelli J; Terasaki PI; Mickey MR
    Transplantation; 1987 May; 43(5):636-40. PubMed ID: 3554654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants.
    Tran TH; Döhler B; Heinold A; Scherer S; Ruhenstroth A; Opelz G
    Transplantation; 2011 Aug; 92(4):419-25. PubMed ID: 21743387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA).
    Morris PJ; Johnson RJ; Fuggle SV; Belger MA; Briggs JD
    Lancet; 1999 Oct; 354(9185):1147-52. PubMed ID: 10513707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
    Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
    N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
    Cecka JM; Terasaki PI
    Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview and epitope matching.
    Terasaki PI; Park MS; Takemoto S; Cecka JM; Clark B; Corcoran S; Cicciarelli J; Barbetti A; Yuge J; Carnahan E
    Clin Transpl; 1989; ():499-516. PubMed ID: 2484860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation in the northwest region of England--experience of 1,132 transplants in 21 years.
    Dyer PA; Martin S; Mallick NP; Gokal R; Johnson RW
    Clin Transpl; 1989; ():201-13. PubMed ID: 2487567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of B locus matching over other HLA matching in renal graft survival.
    Dewar PJ; Wilkinson R; Elliott RW; Ward MK; Kerr DN; Kenward DH; Proud G; Taylor RM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):779-82. PubMed ID: 6802225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant effect of histocompatibility on ten-year kidney transplant survival.
    Takiff H; Cook DJ; Himaya NS; Mickey MR; Terasaki PI
    Transplantation; 1988 Feb; 45(2):410-5. PubMed ID: 3278435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of HLA antigen splits for kidney transplant matching.
    Opelz G
    Lancet; 1988 Jul; 2(8602):61-4. PubMed ID: 2898695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A incompatibility associated with enhanced long-term renal graft survival in HLA-B, DR mismatched transplants.
    Bućin D; Ekberg H; Lindholm A; Persson H; Tufveson G; Albrechtsen D
    Immunol Cell Biol; 1994 Dec; 72(6):455-60. PubMed ID: 7698817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.